Learning Objectives:
1. Raise awareness of hereditary amyloidosis (ATTRv) as a possible diagnosis of idiopathic neuropathy.
2. Discuss what to look for to screen patients at higher risk for ATTRv.
3. Recognize the various advancements in disease modifying therapy.
Session date:
06/18/2024 - 8:00am to 9:00am CDT
Add to calendar:
- 1.00 AMA PRA Category 1 Credit™
- 1.00 Participation
Speaker Name:
Richard Wlodarski, MD